Current decisions on neoadjuvant chemotherapy for early breast cancer: experts ’ experiences in the Netherlands

Neoadjuvant chemotherapy (NAC) is an important initial strategy for the management of operable breast cancer (BC). In accordance with international guidelines, the Dutch national breast cancer guideline recommends NAC as an option for all patients aged5  cm) to increase resectability and the rate of breast conserving surgery and axillary preserving surgery [5].

Source: Patient Education and Counseling - July 18, 2018 Category: International Medicine & Public Health Authors: P.E.R. Spronk, K.M. de Ligt, A.C.M. van Bommel, S. Siesling, C.H. Smorenburg, M.T.F.D. Vrancken Peeters, On behalf of the NABON Breast Cancer Audit Source Type: research